GDRX

GoodRx Holdings, Inc.

NasdaqGSUSDEQUITY DELAYED

3.48

▼ 0.08 (2.31%)

MARKET · —

Price

Open

3.56

Prev close

3.56

Day high

3.60

Day low

3.44

Volume

1.74M

Market cap

—

P/E (TTM)

—

52W range

1.77 – 5.81

Trailing performance

Price return · vs SPY

Returnvs SPY

-7.51% -6.1%

+20.21% +16.5%

+34.77% +31.7%

+39.68% +28.6%

YTD

+27.31% +15.0%

-21.05% -41.1%

-52.35% -126.5%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

3.64

-4.51% from price

SMA 20

3.46

-0.32% from price

SMA 50

3.12

+10.71% from price

SMA 100

2.80

+24.15% from price

SMA 200

2.67

+29.10% from price

EMA 12

3.55

-1.99% from price

EMA 26

3.40

+2.25% from price

EMA 50

3.20

+8.85% from price

RSI (14)

52.5

Neutral

MACD (12,26,9)

0.15

Hist -0.03

ATR (14)

0.22

6.24% of price

Realised vol 30D

56.3%

Annualised

Bollinger upper

3.96

20, 2σ

Bollinger lower

2.96

20, 2σ

50 / 200 cross

Golden

3.12 vs 2.67

Trend bias

Above 200

+29.10%

Risk profile

Daily returns · 1Y window

Beta vs SPY

1.42

More volatile than market

Correlation to SPY

0.30

Largely independent

Realised vol 30D

56.3%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-62.8%

Peak to trough

Max drawdown 5Y

-96.0%

Peak to trough

ATR 14

0.22

6.24% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 3.48

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

GDRX · links out to the publisher

Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX) StockStory · 8d ago 1 Small-Cap Stock with Solid Fundamentals and 2 Facing Headwinds StockStory · 9d ago GoodRx (GDRX) Stock Looks Overvalued On Its Earnings Outlook Simply Wall St. · 9d ago GoodRx Holdings (GDRX) Could Be 13% Overvalued After Q2 Earnings and Guidance Raise Simply Wall St. · 9d ago GoodRx (GDRX) Q2 2026 Earnings Call Transcript Motley Fool · 10d ago GDRX Q2 Deep Dive: Pharma Direct and Subscription Growth Drive Upgraded Outlook StockStory · 11d ago 1 Stock Under $10 with Exciting Potential and 2 Facing Headwinds StockStory · 12d ago Morgan Stanley Adjusts Price Target on GoodRx to $4 From $3, Maintains Equalweight Rating MT Newswires · 15d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.